Urinary incontinence in women is not necessarily progressive, but rather it is a dynamic process, Austrian researchers have concluded.
DexCom, Inc., of San Diego has received approval for its DM Consumer Data Manager, a software program that allows diabetic patients to download and view up to 30 days of historical glucose data from their DexCom STS Continuous Glucose Monitoring Systems.
Eli Lilly and Company has received an approvable letter from the FDA requesting additional supporting data for its new drug application for ruboxistaurin mesylate (proposed trade name: Arxxant), Lilly’s investigational oral therapy for diabetic retinopathy.
ATLANTA—Delayed intervention for treating small renal masses may be appropriate for selected patients, especially those with competing comorbidities, a study found. This conservative approach has little adverse effect on pathological and clinical outcomes, researchers note.